126 related articles for article (PubMed ID: 11961666)
1. Suppression of metastatic hemangiosarcoma by a parvovirus MVMp vector transducing the IP-10 chemokine into immunocompetent mice.
Giese NA; Raykov Z; DeMartino L; Vecchi A; Sozzani S; Dinsart C; Cornelis JJ; Rommelaere J
Cancer Gene Ther; 2002 May; 9(5):432-42. PubMed ID: 11961666
[TBL] [Abstract][Full Text] [Related]
2. MCP-3 (CCL7) delivered by parvovirus MVMp reduces tumorigenicity of mouse melanoma cells through activation of T lymphocytes and NK cells.
Wetzel K; Struyf S; Van Damme J; Kayser T; Vecchi A; Sozzani S; Rommelaere J; Cornelis JJ; Dinsart C
Int J Cancer; 2007 Mar; 120(6):1364-71. PubMed ID: 17154174
[TBL] [Abstract][Full Text] [Related]
3. Oncolytic murine autonomous parvovirus, a candidate vector for glioma gene therapy, is innocuous to normal and immunocompetent mouse glial cells.
Abschuetz A; Kehl T; Geibig R; Leuchs B; Rommelaere J; Régnier-Vigouroux A
Cell Tissue Res; 2006 Sep; 325(3):423-36. PubMed ID: 16699801
[TBL] [Abstract][Full Text] [Related]
4. B1 lymphocytes and myeloid dendritic cells in lymphoid organs are preferential extratumoral sites of parvovirus minute virus of mice prototype strain expression.
Raykov Z; Savelyeva L; Balboni G; Giese T; Rommelaere J; Giese NA
J Virol; 2005 Mar; 79(6):3517-24. PubMed ID: 15731246
[TBL] [Abstract][Full Text] [Related]
5. Highly efficient transduction and expression of cytokine genes in human tumor cells by means of autonomous parvovirus vectors; generation of antitumor responses in recipient mice.
Haag A; Menten P; Van Damme J; Dinsart C; Rommelaere J; Cornelis JJ
Hum Gene Ther; 2000 Mar; 11(4):597-609. PubMed ID: 10724038
[TBL] [Abstract][Full Text] [Related]
6. Activation of a glioma-specific immune response by oncolytic parvovirus Minute Virus of Mice infection.
Grekova SP; Raykov Z; Zawatzky R; Rommelaere J; Koch U
Cancer Gene Ther; 2012 Jul; 19(7):468-75. PubMed ID: 22539062
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral coinjection of two adenoviral vectors expressing functional interleukin-18 and inducible protein-10, respectively, synergizes to facilitate regression of established tumors.
Liu Y; Huang H; Saxena A; Xiang J
Cancer Gene Ther; 2002 Jun; 9(6):533-42. PubMed ID: 12032664
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Parvoviruses Armed to Deliver CXCL4L1 and CXCL10 Are Impaired in Their Antiangiogenic and Antitumoral Effects in a Kaposi Sarcoma Tumor Model Due To the Chemokines' Interference with the Virus Cycle.
Dinsart C; Pervolaraki K; Stroh-Dege A; Lavie M; Ronsse I; Rommelaere J; Van Damme J; Van Raemdonck K; Struyf S
Hum Gene Ther; 2017 Mar; 28(3):295-306. PubMed ID: 28042949
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of adoptive T-cell therapy and intratumoral interferon gamma-inducible protein-10 transgene expression in treatment of established tumors.
Huang H; Liu Y; Xiang J
Cell Immunol; 2002; 217(1-2):12-22. PubMed ID: 12425997
[TBL] [Abstract][Full Text] [Related]
10. Tumor-selective gene transduction and cell killing with an oncotropic autonomous parvovirus-based vector.
Dupont F; Avalosse B; Karim A; Mine N; Bosseler M; Maron A; Van den Broeke AV; Ghanem GE; Burny A; Zeicher M
Gene Ther; 2000 May; 7(9):790-6. PubMed ID: 10822306
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of lymphotactin and interferon gamma-inducible protein-10 transgene expression in T-cell localization and adoptive T-cell therapy of tumors.
Huang H; Xiang J
Int J Cancer; 2004 May; 109(6):817-25. PubMed ID: 15027114
[TBL] [Abstract][Full Text] [Related]
13. Humoral immune responses against minute virus of mice vectors.
Lang SI; Giese NA; Rommelaere J; Dinsart C; Cornelis JJ
J Gene Med; 2006 Sep; 8(9):1141-50. PubMed ID: 16800041
[TBL] [Abstract][Full Text] [Related]
14. Translation control by protein kinase R restricts minute virus of mice infection: role in parvovirus oncolysis.
Ventoso I; Berlanga JJ; Almendral JM
J Virol; 2010 May; 84(10):5043-51. PubMed ID: 20219905
[TBL] [Abstract][Full Text] [Related]
15. Chimeric and pseudotyped parvoviruses minimize the contamination of recombinant stocks with replication-competent viruses and identify a DNA sequence that restricts parvovirus H-1 in mouse cells.
Wrzesinski C; Tesfay L; Salomé N; Jauniaux JC; Rommelaere J; Cornelis J; Dinsart C
J Virol; 2003 Mar; 77(6):3851-8. PubMed ID: 12610161
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of viral vector-mediated antiangiogenic gene transfer in malignant ascites.
Hampl M; Tanaka T; Albert PS; Lee J; Ferrari N; Fine HA
Hum Gene Ther; 2001 Sep; 12(14):1713-29. PubMed ID: 11560766
[TBL] [Abstract][Full Text] [Related]
17. TNF-alpha and the IFN-gamma-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma.
Enderlin M; Kleinmann EV; Struyf S; Buracchi C; Vecchi A; Kinscherf R; Kiessling F; Paschek S; Sozzani S; Rommelaere J; Cornelis JJ; Van Damme J; Dinsart C
Cancer Gene Ther; 2009 Feb; 16(2):149-60. PubMed ID: 18670452
[TBL] [Abstract][Full Text] [Related]
18. Method for concentrating and purifying recombinant autonomous parvovirus vectors designed for tumour-cell-targeted gene therapy.
Avalosse B; Dupont F; Spegelaere P; Mine N; Burny A
J Virol Methods; 1996 Dec; 62(2):179-83. PubMed ID: 9002076
[TBL] [Abstract][Full Text] [Related]
19. A novel MVMp-based vector system specifically designed to reduce the risk of replication-competent virus generation by homologous recombination.
Dupont F; Karim A; Dumon JC; Mine N; Avalosse B
Gene Ther; 2001 Jun; 8(12):921-9. PubMed ID: 11426332
[TBL] [Abstract][Full Text] [Related]
20. The infectivity and lytic activity of minute virus of mice wild-type and derived vector particles are strikingly different.
Lang SI; Boelz S; Stroh-Dege AY; Rommelaere J; Dinsart C; Cornelis JJ
J Virol; 2005 Jan; 79(1):289-98. PubMed ID: 15596824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
